SCHEMBL6038530

SCHEMBL6038530

COc1ccc(N=O)c([C]=O)c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
HPGD P15428 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP3A4 P08684 2/20 0.40
KDM4E B2RXH2 5/20 0.36
CYP1A2 P05177 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 4/20 0.36
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ACHE P22303 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676294 0.82 TDP1 (0.41) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL11508590 0.77 TDP1 (0.38) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL6038534 0.73 ERN1 (0.41) ALDH1A1HPGDTDP1KDM4ECYP1A2
SCHEMBL3126914 0.72 CYP3A4 (0.58) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL439080 0.68 MAPT (0.40) ALDH1A1HPGDTDP1KDM4EMAPT
SCHEMBL28167698 0.68 ALDH1A1 (0.41) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL27512917 0.68 ALDH1A1 (0.43) ALDH1A1HPGDTDP1KDM4EL3MBTL1
SCHEMBL27189267 0.68 CYP3A4 (0.53) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL30701949 0.67 CA9 (0.50) ALDH1A1HPGDTDP1CYP3A4KDM4E
SCHEMBL3674074 0.67 CA9 (0.50) ALDH1A1HPGDTDP1CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060210452-A1 Very large scale immobilized polymer synthesis AFFYMAX TECHNOLOGIES, N.V., A NETHERLANDS ANTILLES CORPORATION 2006-09-21 US disclosed
US-20060194258-A1 Polypeptide array synthesis AFFYMETRIX, INC. (US) 2006-08-31 US disclosed
US-7087732-B2 Nucleotides and analogs having photoremovable protecting groups AFFYMETRIX, INC. (US) 2006-08-08 US disclosed
US-6955915-B2 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-10-18 US disclosed
US-20050208537-A1 Very large scale immobilized polymer synthesis AFFYMETRIX, INC. (US) 2005-09-22 US disclosed
US-6919211-B1 Polypeptide arrays AFFYMETRIX, INC. (US) 2005-07-19 US disclosed
US-20050153362-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 US disclosed
US-20050153363-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 US disclosed
US-20050118706-A1 Polymer arrays AFFYMETRIX, INC. (US) 2005-06-02 US disclosed
US-20050095652-A1 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-05-05 US disclosed
US-6124102-A EVALUATING THE BINDING OF COMPOUNDS TO BINDING PROTEINS; INCUBATION OF LABELLED BINDING PROTEIN TO SUBSTRATE, ANALYZE PIXEL INTENSITY AT KNOWN POSITIONS, USE COMPUTER TO ANALYZE RELATIVE BINDING OF COMPOUNDS TO BINDING PROTEIN AFFYMETRIX, INC. (US) 2000-09-26 US disclosed
US-5889165-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1999-03-30 US disclosed
US-5753788-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1998-05-19 US disclosed
US-5744101-A Photolabile nucleoside protecting groups AFFYMAX TECHNOLOGIES N.V. (GB) 1998-04-28 US disclosed
US-5744305-A Arrays of materials attached to a substrate AFFYMETRIX, INC. (US) 1998-04-28 US disclosed
US-5489678-A 6-NITRO-1,3-BENZOXAZOL-5-YL ALKYLOXY PROTECTIVE GROUP ON THE 5' POSITION OF A DEOXYNUCLEOSIDE; COMPUTERIZED SOLID PHASE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (NL) 1996-02-06 US disclosed
US-5424186-A Biosynthesis of oligonucleotides on solid substrate by irradiation of predefined segments to remove blocking agents; then coupling with nucleotide AFFYMAX TECHNOLOGIES N.V. (AN) 1995-06-13 US disclosed
EP-0562025-A4 1994-03-30 EP disclosed
EP-0562025-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1993-09-29 EP disclosed
WO-1992010092-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1992-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194258-A1 Polypeptide array synthesis MRPL21, NGLY1, PSAP ALDH1A1 4233/4885HPGD 4108/4885TDP1 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.